Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-04FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Ltd)
The FDA approved a supplemental application for divalproex sodium submitted by Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2015-12-26FDA Approved: VALPROIC ACID — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for valproic acid from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2015-12-18FDA Approved: ZOLMITRIPTAN — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Zolmitriptan from Cipla USA Inc., granting continued authorization for the drug's use.
-
FDA approval · 2015-11-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Zydus Pharmaceuticals USA Inc. The specific changes covered by th…
-
FDA approval · 2015-11-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' supplemental application for Divalproex Sodium under ANDA078239, granting approval of a generic product…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-23FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for Sumatriptan by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-11-23FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Sumatriptan from Sun Pharmaceutical Industries, Inc., modifying the product's existing appro…
-
FDA approval · 2015-11-19FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for IMITREX (sumatriptan) from GlaxoSmithKline LLC.
-
FDA approval · 2015-11-17FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application to Haleon US Holdings LLC to add Excedrin Migraine GelTabs (acetaminophen, aspirin, caffeine) fo…
-
FDA approval · 2015-11-10FDA Approved: SUMATRIPTAN — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for Sumatriptan (generic) submitted by Golden State Medical Supply, Inc., for an approved generic pr…
-
FDA approval · 2015-11-09FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application to bring a generic rizatriptan benzoate tablet to market, expanding access for the treatment of acut…
-
FDA approval · 2015-11-09FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Rizatriptan Benzoate by Rising Pharma Holdings, Inc., authorizing a generic version of rizatript…
-
FDA approval · 2015-11-09FDA Approved: ALMOTRIPTAN MALATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Almotriptan Malate from Mylan as an original application generic product for the acute treatment of migraine in adults.
-
FDA approval · 2015-11-06FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Rizatriptan Benzoate by Teva Pharmaceuticals USA, Inc., approving an updated indication/label fo…
-
FDA approval · 2015-10-30FDA Approved: TOPIRAMATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for Topiramate, updating the approved labeling for the product.
-
FDA approval · 2015-10-30FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate submitted by Zydus Lifesciences Limited.
-
FDA approval · 2015-10-12FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for TROKENDI XR (topiramate) filed by Supernus Pharmaceuticals, Inc., indicating an expanded or upda…
-
FDA approval · 2015-09-30FDA Approved: ZOLMITRIPTAN — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's original application for zolmitriptan (generic) tablets.
-
FDA approval · 2015-09-23FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, adding the sprinkle formulation to the produ…
-
FDA approval · 2015-09-23FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2015-09-23FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
-
FDA approval · 2015-09-18FDA Approved: RELPAX — Supplemental Application (ROERIG)
FDA approves a supplemental application for RELPAX (eletriptan hydrobromide) submitted by ROERIG. This approval relates to an existing RELPA…
-
FDA approval · 2015-09-17FDA Approved: ZOLMITRIPTAN OD — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista's generic Zolmitriptan OD for the acute treatment of migraine in adults.
-
FDA approval · 2015-09-11FDA Approved: SUMATRIPTAN — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for sumatriptan submitted by Eugia US LLC under the ANDA program. The approval pertains to an update…
-
FDA approval · 2015-09-10FDA Approved: NARATRIPTAN — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naratriptan from Bionpharma Inc., indicating regulatory approval related to the generic product.